PBE ETF

PBE ETF
$96.72
See how much of PBE you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

NTRA is PBE's largest holding at 6.31% of the fund as of Oct 4, 2026. PBE is Invesco Biotechnology and Genome ETF.

Showing top 34 of 34 holdings · as of Oct 4, 2026
PBE holdings, by weight
#TickerNameWeightCumulativeSharesMkt valueSectorIndustry
1
NTRA
Natera IncHealth Care · Biotechnology
6.31%		6.3%64,039$26.28MHealth CareBiotechnology
2
ILMN
Illumina, Inc.Health Care · Life Sciences Tools
6.29%		12.6%95,837$26.17MHealth CareLife Sciences Tools
Sector and industry · Pro
3
BIIB
Biogen Inc.
5.16%		17.8%97,669$21.48M
4
GILD
Gilead Sciences Inc
5.04%		22.8%144,938$20.98M
5
RPRX
Royalty Pharma Plc Class A Ordinary Share
4.77%		27.6%347,388$19.86M
6
VRTX
Vertex Pharmaceuticals Inc
4.73%		32.3%39,002$19.69M
7
AMGN
Amgen Inc.
4.72%		37.0%48,758$19.65M
8
REGN
Regeneron Pharmaceuticals, Inc.
4.57%		41.6%25,867$19.02M
9
MRNA
Moderna Inc
3.38%		45.0%74,053$14.07M
10
NVAX
Novavax Inc
3.13%		48.1%1,245,901$13.03M
11
UTHR
United Therapeutics Corp
2.95%		51.1%22,683$12.29M
12
VCYT
Veracyte, Inc.
2.94%		54.0%267,059$12.23M
13
EXEL
Exelixis Inc
2.91%		56.9%207,358$12.11M
14—Qiagen Nv Ord
2.90%		59.8%269,446$12.06M
15
HALO
Halozyme Therapeutics Inc
2.84%		62.6%107,586$11.82M
16
RGEN
Repligen Corp
2.83%		65.5%64,733$11.76M
17
TGTX
Tg Therapeutics Inc
2.77%		68.2%212,222$11.52M
18
NBIX
Neurocrine Biosciences Inc
2.64%		70.9%76,686$10.98M
19
PTGX
Protagonist Therapeutics Inc
2.63%		73.5%78,102$10.94M
20
VCEL
Vericel Corp
2.63%		76.1%272,127$10.93M
21
SRPT
Sarepta Therapeutics Inc
2.61%		78.7%621,634$10.88M
22
INCY
Incyte Corp.
2.51%		81.3%90,666$10.45M
23
ARDX
Ardelyx Inc
2.50%		83.8%3,111,456$10.39M
24
LEGN
Legend Biotech Corp-adr
2.46%		86.2%552,174$10.25M
25
BMRN
Biomarin Pharmaceutical Inc.
2.44%		88.7%177,878$10.17M
26
PTCT
Ptc Therapeutics Inc
2.44%		91.1%160,083$10.16M
27
ANAB
Anaptysbio Inc
2.35%		93.4%201,495$9.78M
28
BCRX
BioCryst Pharmaceuticals Inc.
2.35%		95.8%1,196,471$9.78M
29
COLL
Collegium Pharmaceutical Inc
2.27%		98.1%428,151$9.43M
30
ACAD
Acadia Pharmaceuticals Inc
1.84%		99.9%384,733$7.68M
31
AGPXX
Invesco Government & Agency Portfolio, Institutional Class
0.08%		100.0%342,800$342.8K
32—Cash & Equivalents
0.00%		100.0%5,728$5.7K
33—USD Pending Dividends %
0.00%		100.0%-$35
34—Securities Lending - Bnym %
0.00%		100.0%1-
Not reported for this fund: share changes.
FundXLS Pro
See every sector, industry and share-change value
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

PBE ETF All Holdings

PBE holdings total 68 positions. The top 10 holdings account for 48.1% of the fund, led by Natera Inc at 6.3%, Illumina, Inc. at 6.3%, Biogen Inc. at 5.2%.

PBE portfolio concentration is moderate, with the top 10 representing 48.1% of total assets. The largest sector exposure is Health Care at 92.2%.

PBE sectors provide a detailed breakdown. PBE overlap shows how holdings compare to other funds in your portfolio.

Compare PBE

PBE vs SPYPBE vs QQQPBE vs VOOPBE vs VTIPBE vs IVVPBE vs SCHDPBE vs VYMPBE vs VXUS

PBE ETF Holdings

34 of 68 holdings

  • 1

    Natera Inc

    NTRAHealth Care
    6.31%
  • 2

    Illumina, Inc.

    ILMNHealth Care
    6.29%
  • 3

    Biogen Inc.

    BIIBHealth Care
    5.16%
  • 4

    Gilead Sciences Inc

    GILDHealth Care
    5.04%
  • 5

    Royalty Pharma Plc Class A Ordinary Share

    RPD:DUFinancials
    4.77%
  • 6

    Vertex Pharmaceuticals Inc

    VRTXHealth Care
    4.73%
  • 7

    Amgen Inc.

    AMGNHealth Care
    4.72%
  • 8

    Regeneron Pharmaceuticals, Inc.

    REGNHealth Care
    4.57%
  • 9

    Moderna Inc

    MRNAHealth Care
    3.38%
  • 10

    Novavax Inc

    NVAXHealth Care
    3.13%
  • 11

    United Therapeutics Corp

    UTHRHealth Care
    2.95%
  • 12

    Veracyte, Inc.

    VCYTHealth Care
    2.94%
  • 13

    Exelixis Inc

    EXELHealth Care
    2.91%
  • 14

    Qiagen Nv Ord

    QGEN:ASUnknown
    2.90%
  • 15

    Halozyme Therapeutics Inc

    HALOHealth Care
    2.84%
  • 16

    Repligen Corp

    RGENHealth Care
    2.83%
  • 17

    Tg Therapeutics Inc Common Stock

    TGTXHealth Care
    2.77%
  • 18

    Neurocrine Biosciences Inc

    NBIXHealth Care
    2.64%
  • 19

    Protagonist Therapeutics Inc

    PTGXHealth Care
    2.63%
  • 20

    Vericel Corp

    VCELHealth Care
    2.63%
  • 21

    Sarepta Therapeutics Inc

    SRPTHealth Care
    2.61%
  • 22

    Incyte Corp.

    INCYHealth Care
    2.51%
  • 23

    Ardelyx Inc

    ARDXHealth Care
    2.50%
  • 24

    LEGEND BIOTECH CORP-ADR

    LEGNHealth Care
    2.46%
  • 25

    Biomarin Pharmaceutical Inc.

    BMRNHealth Care
    2.44%
  • 26

    Ptc Therapeutics Inc

    PTCTHealth Care
    2.44%
  • 27

    Anaptysbio Inc

    ANABHealth Care
    2.35%
  • 28

    BioCryst Pharmaceuticals Inc.

    BCRXHealth Care
    2.35%
  • 29

    Collegium Pharmaceutical Inc

    COLLHealth Care
    2.27%
  • 30

    Acadia Pharmaceuticals Inc

    ACADHealth Care
    1.84%
  • 31

    Invesco Government & Agency Portfolio, Institutional Class

    AGPXXFinancials
    0.08%
  • 32

    Cash & Equivalents

    Other
    0.00%
  • 33

    USD Pending Dividends %

    Other
    0.00%
  • 34

    Securities Lending - Bnym %

    Other
    0.00%